Dupixent 300 MG/2 ML syringe 2ML

Ended Awarded

Contract number
SPE2DB24FQDQ3
Awardee
Awarding agency
Obligated
$34,700

Award facts

Contract value 100% obligated
$34,699.56 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $34,699.56 to AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. The contract is for the supply of Dupixent 300 mg/2 ml syringes and has an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00, which serves as the primary contract vehicle for the company to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order does not have a set-aside designation.

Quick answers

Who was awarded contract SPE2DB24FQDQ3?

SPE2DB24FQDQ3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 12, 2024.

How much is contract SPE2DB24FQDQ3 worth?

The government has obligated $34,700 on SPE2DB24FQDQ3.

Is contract SPE2DB24FQDQ3 an order under another contract?

Yes. SPE2DB24FQDQ3 is a delivery order under SPE2DB20D7059, an indefinite delivery contract.

Was contract SPE2DB24FQDQ3 competed?

The extent of competition for SPE2DB24FQDQ3 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award